Investigator

Rondell P Graham

GI/Liver and Molecular Pathologist · Mayo Clinic Rochester, Department of Laboratory Medicine and Pathology

RPGRondell P Graham
Papers(1)
Mucinous cystic neopl…
Collaborators(7)
Yoh ZenBilge DundarDaniela S AllendeMaria WesterhoffMichelle D ReidN Volkan AdsayRish K Pai
Institutions(6)
Mayo ClinicKings College HospitalCleveland Clinic Lern…University Of MichiganEmory University Hosp…Koç Üniversitesi Tıp …

Papers

Mucinous cystic neoplasm in men: a comparative study

AimsMucinous cystic neoplasms (MCN) are defined by the presence of an ovarian‐type stroma (OTS). Once ovarian stroma has become a requirement for the diagnosis of MCNs, studies using this criterion have disclosed that MCNs are seen almost exclusively (97%) in women. The occurrence of MCNs (with ovarian stroma) in men is exceedingly rare and raises questions about the origin of OTS and the role of hormones in tumourigenesis. This study aims to investigate the clinical and histopathological features of pancreatic or hepatic MCNs in men.Methods and resultsWe examined the MCN cases in men and compared them with age‐matched women. We further investigated MCN in premenopausal and postmenopausal women to explore the impact of hormonal status.The stromal cellularity tended to be lower in men as compared to women; however, limited numbers prevented statistical significance. Clinical presentation, tumour location, body mass index and cyst complexity were similar between men and age‐matched women, similarly in pre‐ and postmenopausal woman groups. All MCN cases, regardless of gender or hormonal status, showed OTS with positivity for oestrogen receptor (ER), androgen receptor (AR) and SF‐1 immunostains. Additionally, the presence of AR and ER‐beta in lining epithelial cells, in addition to the stromal cells, raised the probability for a potential role for local hormonal signalling in the pathogenesis of these tumours.ConclusionsMCNs in men had overlapping histopathologic and immunohistochemical profiles with those in women, regardless of menopausal status.

365Works
1Papers
7Collaborators
Biomarkers, TumorPrognosisColorectal NeoplasmsLiver NeoplasmsPancreatic NeoplasmsNeoplasm StagingTumor MicroenvironmentNeoplasm Recurrence, Local

Positions

2016–

GI/Liver and Molecular Pathologist

Mayo Clinic Rochester · Department of Laboratory Medicine and Pathology

Education

2009

MBBS

Mayo Clinic Minnesota · Department of Laboratory Medicine and Pathology

Country

US

Keywords
Fibrolamellar CarcinomaHepatocellular CarcinomaLiver neoplasmsPRKACA
Links & IDs
0000-0002-8686-4867

Scopus: 53979541600